Vascular endothelial growth factor-A and chemokine ligand (CCL2) genes are upregulated in peripheral blood mononuclear cells in Indian amyotrophic lateral sclerosis patients

Journal of Neuroinflammation

Volumn 8, Issue , 2011, Pages

  Gupta, Pawan K ^a   Prabhakar, Sudesh ^a   Abburi, Chandrika ^a   Sharma, Neel K ^a   Anand, Akshay ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; VASCULOTROPIN A; CCL2 PROTEIN, HUMAN;

ADULT; ALCOHOL CONSUMPTION; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CCL2 GENE; CIGARETTE SMOKING; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENE; GENE EXPRESSION; HUMAN; HUMAN CELL; INDIAN; MALE; MEAT; PERIPHERAL BLOOD MONONUCLEAR CELL; REAL TIME POLYMERASE CHAIN REACTION; RESPIRATORY TRACT DISEASE; SURVIVAL TIME; UPREGULATION; VEGF A GENE; ASIAN; BLOOD; GENETICS; INDIA; METABOLISM; METHODOLOGY; MIDDLE AGED; MONONUCLEAR CELL; PATHOPHYSIOLOGY; PHYSIOLOGY; POLYMERASE CHAIN REACTION;

ADULT; AMYOTROPHIC LATERAL SCLEROSIS; ASIAN CONTINENTAL ANCESTRY GROUP; CHEMOKINE CCL2; FEMALE; HUMANS; INDIA; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; RNA, MESSENGER; UP-REGULATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 80052599853     PISSN: None     EISSN: 17422094     Source Type: Journal    
DOI: 10.1186/1742-2094-8-114     Document Type: Article

References (30)

1. Carmeliet P. Mechanisms of angiogenesis and arteriogenesis. Nat Med 2000, 6:389-395. 10.1038/74651, 10742145.
2. Storkebaum E, Lambrechts D, Carmeliet P. VEGF: once regarded as a specific angiogenic factor, now implicated in neuroprotection. Bioessays 2004, 26:943-954. 10.1002/bies.20092, 15351965.
3. Oosthuyse B, Moons L, Storkebaum E, Beck H, Nuyens D, Brusselmans K, Van Dorpe J, Hellings P, Gorselink M, Heymans S, Theilmeier G, Dewerchin M, Laudenbach V, Vermylen P, Raat H, Acker T, Vleminckx V, Van Den Bosch L, Cashman N, Fujisawa H, Drost MR, Sciot R, Bruyninckx F, Hicklin DJ, Ince C, Gressens P, Lupu F, Plate KH, Robberecht W, Herbert JM, Collen D, Carmeliet P. Deletion of the hypoxia-response element in the vascular endothelial growth factor promoter causes motor neuron degeneration. Nat Genet 2001, 28:131-138. 10.1038/88842, 11381259.
4. Hwang DH, Lee HJ, Park IH, Seok JI, Kim BG, Joo IS, Kim SU. Intrathecal transplantation of human neural stem cells overexpressing VEGF provide behavioral improvement, disease onset delay and survival extension in transgenic ALS mice. Gene Ther 2009, 10:1234-1244.
5. Madrigal JL, Leza JC, Polak P, Kalinin S, Feinstein DL. Astrocyte-derived MCP-1 mediates neuroprotective effects of noradrenaline. J Neurosci 2009, 29:263-267. 10.1523/JNEUROSCI.4926-08.2009, 19129402.
6. Nalini A, Thennarasu K, Gourie-Devi M, Shenoy S, Kulshreshtha D. Clinical characteristics and survival pattern of 1,153 patients with amyotrophic lateral sclerosis: experience over 30 years from India. J Neurol Sci 2008, 272:60-70. 10.1016/j.jns.2008.04.034, 18550082.
7. Bradley WG. Commentary on Professor Stephen Hawking's disability advice. Annals of Neurosciences 2009, 16:101-102.
8. Sorenson EJ, Stalker AP, Kurland LT, Windebank AJ. Amyotrophic lateral sclerosis in Olmsted County, Minnesota, 1925 to 1998. Neurology 2002, 59:280-282.
9. Gupta PK, Prabhakar S, Sharma S, Anand A. Vascular endothelial growth factor-A (VEGF-A) and chemokine ligand-2 (CCL2) in Amyotrophic Lateral Sclerosis (ALS) patients. Journal of Neuroinflammation 2011, 8:47. 10.1186/1742-2094-8-47, 3117705, 21569455.
10. Cedarbaum JM, Stambler N, Malta E, Fuller C, Hilt D, Thurmond B, Nakanishi A. The ALSFRS-R: a revised ALS functional rating scale that incorporates assessmentsof respiratory function. BDNF ALS Study Group (Phase III). J Neurol Sci 1999, 169:13-21. 10.1016/S0022-510X(99)00210-5, 10540002.
11. Prabhakar S, Vinish M, Das CP, Anand A. Occurrence of PARK2 Mutations in a Never-Smoker Population with Parkinson's Disease in North India. Neuroepidemiology 2010, 35:152-159. 10.1159/000313855, 20571283.
12. Meister B, Grünebach F, Bautz F, Brugger W, Fink FM, Kanz L, Möhle R. Expression of vascular endothelial growth factor (VEGF) and its receptors in human neuroblastoma. Eur J Cancer 1999, 35:445-449. 10.1016/S0959-8049(98)00387-6, 10448297.
13. Ebihara N, Yamagami S, Yokoo S, Amano S, Murakami A. Involvement of C-C chemokine ligand 2-CCR2 interaction in monocyte-lineage cell recruitment of normal human corneal stroma. J Immunol 2007, 178:3288-3292.
14. Henkel JS, Engelhardt JI, Siklos L, Simpson EP, Kim SH, Pan T, Goodman JC, Siddique T, Beers DR, Appel SH. Presence of dendritic cells, MCP-1, and activated microglia/macrophages in amyotrophic lateral sclerosis spinal cord tissue. Ann Neurol 2004, 55:221-235. 10.1002/ana.10805, 14755726.
15. Lu L, Zheng L, Viera L, Suswam E, Li Y, Li X, Estévez AG, King PH. Mutant Cu/Zn-superoxide dismutase associated with amyotrophic lateral sclerosis destabilizes vascular endothelial growth factor mRNA and downregulates its expression. J Neurosci 2007, 30:7929-38.
16. Lambrechts D, Storkebaum E, Morimoto M, Del-Favero J, Desmet F, Marklund SL, Wyns S, Thijs V, Andersson J, van Marion I, Al-Chalabi A, Bornes S, Musson R, Hansen V, Beckman L, Adolfsson R, Pall HS, Prats H, Vermeire S, Rutgeerts P, Katayama S, Awata T, Leigh N, Lang-Lazdunski L, Dewerchin M, Shaw C, Moons L, Vlietinck R, Morrison KE, Robberecht W, Van Broeckhoven C, Collen D, Andersen PM, Carmeliet P. VEGF is a modifier of amyotrophic lateral sclerosis in mice and humans and protects motoneurons against ischemic death. Nat Genet 2003, 34:383-394. 10.1038/ng1211, 12847526.
17. Devos D, Moreau C, Lassalle P, Perez T, De Seze J, Brunaud-Danel V, Destée A, Tonnel AB, Just N. Low levels of the vascular endothelial growth factor in CSF from early ALS patients. Neurology 2004, 62:2127-2129.
18. Nygren I, Larsson A, Johansson A, Askmark H. VEGF-A is increased in serum but not in spinal cord from patients with amyotrophic lateral sclerosis. Neuroreport 2002, 13:2199-2201. 10.1097/00001756-200212030-00007, 12488796.
19. Iłzecka J. Cerebrospinal fluid vascular endothelial growth factor in patients with amyotrophic lateral sclerosis. Clin Neurol Neurosurg 2004, 106:289-93. 10.1016/j.clineuro.2003.12.007, 15297002.
20. Cronin S, Greenway MJ, Ennis S, Kieran D, Green A, Prehn JH, Hardiman O. Elevated serum angiogenin levels in ALS. Neurology 2006, 67:1833-1836. 10.1212/01.wnl.0000244466.46020.47, 17130418.
21. Nagata T, Nagano I, Shiote M, Narai H, Murakami T, Hayashi T, Shoji M, Abe K. Elevation of MCP-1 and MCP-1/VEGF ratio in cerebrospinal fluid of amyotrophic lateral sclerosis patients. Neurol Res 2007, 29:772-776. 10.1179/016164107X229795, 17672928.
22. Manzano R, Toivonen JM, Oliván S, Calvo AC, Moreno-Igoa M, Muñoz MJ, Zaragoza P, García-Redondo A, Osta R. Altered Expression of Myogenic Regulatory Factors in the Mouse Model of Amyotrophic Lateral Sclerosis. Neurodegener Dis 2011, 8:386-396. 10.1159/000324159, 21346327.
23. Bogaert E, Van Damme P, Poesen K, Dhondt J, Hersmus N, Kiraly D, Scheveneels W, Robberecht W, Van Den Bosch L. VEGF protects motor neurons against excitotoxicity by upregulation of GluR2. Neurobiol Aging 2010, 31:2185-2191. 10.1016/j.neurobiolaging.2008.12.007, 19185395.
24. Meng H, Zhang Z, Zhang R, Liu X, Wang L, Robin AM, Chopp M. Biphasic effects of exogenous VEGF on VEGF expression of adult neural progenitors. Neurosci Lett 2006, 393:97-101. 10.1016/j.neulet.2005.09.044, 16269210.
25. Liu XS, Zhang ZG, Zhang RL, Gregg SR, Wang L, Yier T, Chopp M. Chemokine ligand 2 (CCL2) induces migration and differentiation of subventricular zone cells after stroke. J Neurosci Res 2007, 85:2120-2125. 10.1002/jnr.21359, 17510981.
26. Zhao W, Xie W, Le W, Beers DR, He Y, Henkel JS, Simpson EP, Yen AA, Xiao Q, Appel SH. Activated microglia initiate motor neuron injury by a nitric oxide and glutamate-mediated mechanism. J Neuropathol Exp Neurol 2004, 63:964-977.
27. Bartholdi D, Rubin BP, Schwab ME. VEGF mRNA induction correlates with changes in the vascular architecture upon spinal cord damage in the rat. Eur J Neurosci 1997, 9:2549-2560. 10.1111/j.1460-9568.1997.tb01684.x, 9517460.
28. Rosenstein JM, Krum JM. New roles for VEGF in nervous tissue--beyond blood vessels. Exp Neurol 2004, 187:246-253. 10.1016/j.expneurol.2004.01.022, 15144851.
29. Zheng C, Sköld MK, Li J, Nennesmo I, Fadeel B, Henter JI. VEGF reduces astrogliosis and preserves neuromuscular junctions in ALS transgenic mice. Biochem Biophys Res Commun 2007, 363:989-993. 10.1016/j.bbrc.2007.09.088, 17923114.
30. Cui LY, Liu MS, Tang XF. Single fiber electromyography in 78 patients with amyotrophic lateral sclerosis. Chin Med J (Engl) 2004, 117:1830-1833.